هذه المراجع ستظهر في المقال، ولكن هذه القائمة تظهر فقط في هذه الصفحة.
^Marx J (2006). Rosen's emergency medicine : concepts and clinical practice (6th ed.). Philadelphia: Mosby/Elsevier. p. 2239. ISBN978-0-323-02845-5. OCLC58533794.
^Hutchison JS, Ward RE, Lacroix J, Hébert PC, Barnes MA, Bohn DJ, et al. (June 2008). "Hypothermia therapy after traumatic brain injury in children". The New England Journal of Medicine. 358 (23): 2447–56. doi:10.1056/NEJMoa0706930. PMID18525042.
^Grunau BE, Wiens MO, Brubacher JR (September 2010). "Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review". Cjem. 12 (5): 435–42. doi:10.1017/s1481803500012598. PMID20880437. Dantrolene may also be associated with improved survival and reduced complications, especially in patients with extreme (≥ 42 °س) or severe (≥ 40 °C) hyperpyrexia
^Sharma HS, ed. (2007). Neurobiology of Hyperthermia (1st ed.). Elsevier. pp. 175–177, 485. ISBN9780080549996. Retrieved 19 November 2016. Despite the myriad of complications associated with heat illness, an elevation of core temperature above 41.0 °س (often referred to as fever or hyperpyrexia) is the most widely recognized symptom of this syndrome.